Atlas Trials

Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors

Clinical trial NCT06612645 · RECRUITING

Trial details

NCT number
NCT06612645
Sponsor
Chulalongkorn University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Pediatric CancersSolid Tumor Pediatric
Start date
2025-04-01
Primary completion
2027-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.